全文获取类型
收费全文 | 18576篇 |
免费 | 1988篇 |
国内免费 | 46篇 |
专业分类
耳鼻咽喉 | 151篇 |
儿科学 | 639篇 |
妇产科学 | 648篇 |
基础医学 | 2616篇 |
口腔科学 | 355篇 |
临床医学 | 2173篇 |
内科学 | 3776篇 |
皮肤病学 | 185篇 |
神经病学 | 1416篇 |
特种医学 | 575篇 |
外科学 | 2588篇 |
综合类 | 576篇 |
一般理论 | 43篇 |
预防医学 | 2284篇 |
眼科学 | 294篇 |
药学 | 1376篇 |
中国医学 | 15篇 |
肿瘤学 | 900篇 |
出版年
2021年 | 312篇 |
2020年 | 197篇 |
2019年 | 297篇 |
2018年 | 326篇 |
2017年 | 260篇 |
2016年 | 242篇 |
2015年 | 275篇 |
2014年 | 404篇 |
2013年 | 617篇 |
2012年 | 832篇 |
2011年 | 937篇 |
2010年 | 489篇 |
2009年 | 462篇 |
2008年 | 760篇 |
2007年 | 812篇 |
2006年 | 746篇 |
2005年 | 795篇 |
2004年 | 708篇 |
2003年 | 695篇 |
2002年 | 658篇 |
2001年 | 603篇 |
2000年 | 640篇 |
1999年 | 545篇 |
1998年 | 255篇 |
1997年 | 210篇 |
1996年 | 228篇 |
1995年 | 207篇 |
1994年 | 175篇 |
1993年 | 163篇 |
1992年 | 434篇 |
1991年 | 482篇 |
1990年 | 445篇 |
1989年 | 413篇 |
1988年 | 357篇 |
1987年 | 386篇 |
1986年 | 354篇 |
1985年 | 340篇 |
1984年 | 287篇 |
1983年 | 239篇 |
1982年 | 153篇 |
1981年 | 146篇 |
1979年 | 192篇 |
1978年 | 145篇 |
1977年 | 153篇 |
1976年 | 126篇 |
1975年 | 117篇 |
1974年 | 182篇 |
1973年 | 163篇 |
1972年 | 131篇 |
1970年 | 133篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
41.
42.
Collateral sensitivity to nitrosoureas in multidrug-resistant cells selected with verapamil. 总被引:3,自引:0,他引:3
We have examined the effects of the nitrosoureas, streptozotocin (STZ) and 1,3-bis(chloroethyl)-1-nitrosourea (BCNU), on a human multiple myeloma cell line, RPMI 8226, and its drug-resistant variants. Cell lines selected for doxorubicin (DOX) resistance alone displayed a STZ and BCNU cytotoxicity profile similar to that of the parent cell line. In contrast, two of the drug-resistant variants selected with DOX plus verapamil, an agent which inhibits P-glycoprotein-mediated multidrug resistance, displayed a collateral sensitivity to STZ and BCNU. Verapamil was included in the selection protocol because it has been shown to inhibit the P-glycoprotein-mediated multidrug resistance phenotype and is now in clinical trials as a chemosensitizing agent. The collateral sensitivity to these nitrosoureas seen in the DOX plus verapamil-selected cell lines is due to the functional loss of a DNA repair molecule, O6-Methylguanine DNA methyltransferase (MGMT). The functional loss of MGMT is secondary to the loss of MGMT gene expression. The loss of MGMT gene expression is not due to loss or gross rearrangement of the MGMT-coding region. If this selection pressure applied in vitro reflects the in vivo situation, then new chemotherapeutic strategies may be devised to exploit this phenomenon. These cell lines will serve as useful models for delineating mechanisms which govern MGMT expression. 相似文献
43.
Iain L. Campbell 《Journal of neuroimmunology》1996,71(1-2)
To elucidate the possible involvement of the inducible nitric oxide synthase (iNOS) and NO in the development of lymphocytic choriomeningitis (LCM), the consequences of inhibition of iNOS by the inhibitor aminoguanidine was examined in mice following intracerebral infection with LCM virus (LCMV). Aminoguanidine administration to mice infected with LCMV completely blocked increased plasma nitrate/nitrite levels and led to increased proinflammatory cytokine gene expression at early stages of lesion development in the brain, enhanced clinical severity and decreased survival time. The levels of LCMV recovered from the brain of aminoguanidine treated mice did not differ from those in infected control mice. These findings argue against either an anti-viral or pathogenic role of NO in LCM but rather suggest a possible protective action of this mediator. 相似文献
44.
Efficacy of the dorsal pedal bypass for limb salvage in diabetic patients: short-term observations 总被引:1,自引:0,他引:1
F B Pomposelli S J Jepsen G W Gibbons D R Campbell D V Freeman A Miller F W LoGerfo 《Journal of vascular surgery》1990,11(6):745-51; discussion 751-2
Limbs of diabetic patients with distal tibial disease are frequently considered unreconstructible; however, when studied with intraarterial digital subtraction angiography, the dorsal pedal artery is frequently found to be patent. We have reviewed our recent experience with 96 patients, 94% of whom had diabetes and had 97 bypasses placed to the dorsal pedal artery. All procedures were for limb salvage. Superimposed infection was present in 42.3%. In 92 instances where intraarterial digital subtraction angiography successfully visualized the dorsal pedal artery, 91 bypasses were placed. In 12 other cases where the dorsal pedal artery was not visualized by intraarterial digital subtraction angiography but audible with the continuous-wave Doppler, bypasses were completed successfully in six. All procedures were performed with vein. Inflow was taken from the femoral artery in 48, popliteal artery in 45, tibial artery in 2, and from a femoral tibial graft in 2. Perioperative mortality was 1.92%. Actuarial graft patency, limb salvage, and patient survival were 82%, 87%, and 80%, respectively at 18 months. We conclude that bypass grafting to the dorsal pedal artery can be reliably performed with acceptable short-term results. An attempt should always be made to visualize the foot vessels angiographically, especially in diabetic patients, so that this valuable option in arterial reconstruction will not be overlooked. 相似文献
45.
7-甲氧基-4′-羟基-3′-二乙胺甲基异黄酮(MHDF)对大鼠血流动力学和主动脉的作用 总被引:2,自引:0,他引:2
本实验观察了MHDF对整体大鼠血流动力学和离体大鼠胸主动脉的作用。结果表明iv MHDF(3~12.8 mg/kg)能降低大鼠左心室±dp/dtmax,Vmax,Vpm和LVSP,延长T-dp/dtmax,减慢心率。MHDF还能舒张大鼠胸主动脉,ED50为6.5×10-6mol/L;非竞争拮抗NA和CaCl2致主脉收缩,pD2′为3.11±0.21和3.73±0.07;抑制高K+致主动脉收缩,IC50为1.76×10-5mol/L。提示MHDF对血管的作用与α受体阻断剂不同,而可能与钙拮抗有关。 相似文献
46.
M. R. McGinnis G. Campbell W. K. Gourley H. L. Lucia 《European journal of epidemiology》1992,8(3):383-386
A case of phaeohyphomycosis caused by Bipolaris spicifera involving the brain and sinuses is presented. The patient survived following surgery and ketoconazole therapy, which successfully treated both the sinus and the brain infections. 相似文献
47.
This case report represents the first well-documented case of aberrant internal carotid arteries in both middle ears. CT and DSA can establish the diagnosis before surgical intervention. Aberrant internal carotid artery represents a rare finding in the differential diagnosis of middle ear masses. Most patients manifest either vertigo, tinnitus, or a variable hearing loss. Clinical findings include a red or blue mass behind the eardrum that may or may not be pulsatile. The otolaryngologist should be aware that this potential landmine may be obscured by serous otitis media. Once suspected, the mass should be evaluated by radiographic studies before surgical intervention. 相似文献
48.
Sheryl A. Scott Seth Dinowitz Kristen Terhaar Diane Sherlock Maurice A. Campbell Dreania Levine 《The Journal of comparative neurology》1994,350(2):302-310
The goal of the present study was to identify cytochemical markers characteristic of muscle afferents in hatchling chicks. To this end, we stained neurons in the trigeminal mesencephalic nucleus with a variety of markers that label subsets of neurons in avian dorsal root ganglia. We found that trigeminal mesencephalic neurons are surprisingly heterogeneous in their cytochemical make-up, expressing, to varying degrees, substance P, cholecystokinin, carbonic anhydrase, calbindin D-28k, parvalbumin, and S-100β. Calbindin D28k and S-100β appeared to be expressed equally in medial and lateral divisions of the trigeminal mesencephalic nucleus. In contrast, substance P- and cholecystokinin-immunoreactive neurons were more abundant in the medial division, whereas carbonic anhydrase activity and parvalbumin immunoreactivity were stronger in the lateral division. We were unable to detect met-enkephalin, neuropeptide Y, calcitonin gene-related peptide, vasoactive intestinal peptide, somatostatin, γ-aminobutyric acid, or tyrosine hydroxylase in the trigeminal mesencephalic nucleus. Moreover, these neurons did not appear to bind the lectin Dolichos biflorus agglutinin. The heterogeneity of expression of markers among trigeminal mesencephalic nucleus neurons, especially between neurons in the medial and lateral divisions, suggests that these neurons are functionally diverse. 相似文献
49.
N Bellamy W W Buchanan J M Esdaile A G Fam W F Kean J M Thompson G A Wells J Campbell 《The Journal of rheumatology》1991,18(11):1716-1722
Defining the minimum clinically important difference or delta to be detected in a clinical trial depends on a number of factors including the research hypothesis, patient characteristics, the nature of the intervention and the trial design. In 2 previous studies, we have developed standardized procedures for conducting outcome measurement based on current Food and Drug Administration and European League Against Rheumatism guidelines for clinical trials in ankylosing spondylitis, and thereafter, determined the standard deviation for these outcome measures. In the final component of this series of studies, we have employed a Delphi technique to establish estimates for delta, and calculated the sample size requirements under 2 different conditions of Type I and Type II error probabilities. 相似文献
50.